Amundi’s AnaptysBio ANAB Stock Holding History

Amundi’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-256	Closed	-$4.94K	–	1679
2025 Q1	$4.94K	Sell	256 -34	-12%	-$567	﹤0.01%	1917
2024 Q4	$4.16K	Buy	290 +45	+18%	+$1.09K	﹤0.01%	1950
2024 Q3	$7.93K	Buy	+245	New	+$8.37K	﹤0.01%	1936
2023 Q4	–	Sell	-1,538	Closed	-$29K	–	2001
2023 Q3	$29K	Hold	1,538	–	–	﹤0.01%	1905
2023 Q2	$30.2K	Hold	1,538	–	–	﹤0.01%	1939
2023 Q1	$32.8K	Hold	1,538	–	–	﹤0.01%	1929
2022 Q4	$32.8K	Hold	1,538	–	–	﹤0.01%	1753
2022 Q3	$42K	Buy	+1,538	New	+$36.1K	﹤0.01%	1692

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Amundi's ANAB Position: Q2 2025 in Review

Amundi sold out of AnaptysBio (ANAB) in Q2 2025, closing a stake of 256 shares — an estimated $4.94K sold.

Amundi first reported a position in ANAB in Q3 2022 and held it in 8 quarters. The position peaked at $42K in Q3 2022. 147 funds tracked by Wall St. Rank hold ANAB as of Q2 2025.

Amundi reported no remaining AnaptysBio position as of Q2 2025 after selling out during the quarter.
Amundi sold 256 AnaptysBio shares in Q2 2025, an estimated $4.94K.
Amundi first reported a position in AnaptysBio in Q3 2022 and held it in 8 quarters.
Amundi's AnaptysBio position peaked at $42K in Q3 2022.
147 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.